The Costs and Effects of a Nutritional Education Program Following Work-site Cholesterol Screening
Overview
Authors
Affiliations
Objectives: The purpose of this study was to assess the costs and impact of a nutrition education program following a cholesterol screening.
Methods: Forty work-sites were randomly assigned to one of two educational interventions: a "usual" intervention of 5 minutes of counseling, or a "special" intervention of 2 hours of behaviorally based education on dietary changes to lower serum cholesterol. Costs were monitored, and cholesterol levels were retested 6 and 12 months later.
Results: The total per-person cost for screening and the educational intervention was about $50. Cholesterol levels differed little between the two intervention groups 6 months after screening, but after 12 months those in the special intervention worksites showed a 6.5% drop in cholesterol, whereas those at the usual intervention worksites showed a drop of only 3.0%. Hence a 3.5% cholesterol reduction was attributable to the special intervention.
Conclusions: A behaviorally based nutrition education program following cholesterol screening can have a meaningful impact on long-term cholesterol levels at a low cost. Nutrition education in work-sites may therefore be a useful way to lower the risk of heart disease in communities.
Improving Eating Habits at the Office: An Umbrella Review of Nutritional Interventions.
Hyzy A, Jaworski M, Cieslak I, Gotlib-Malkowska J, Panczyk M Nutrients. 2023; 15(24).
PMID: 38140338 PMC: 10745686. DOI: 10.3390/nu15245072.
Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Jimoh O, Kirk C, Foster E, Abdelhamid A Cochrane Database Syst Rev. 2020; 8:CD011737.
PMID: 32827219 PMC: 8092457. DOI: 10.1002/14651858.CD011737.pub3.
Effects of total fat intake on body fatness in adults.
Hooper L, Abdelhamid A, Jimoh O, Bunn D, Skeaff C Cochrane Database Syst Rev. 2020; 6:CD013636.
PMID: 32476140 PMC: 7262429. DOI: 10.1002/14651858.CD013636.
Reduction in saturated fat intake for cardiovascular disease.
Hooper L, Martin N, Jimoh O, Kirk C, Foster E, Abdelhamid A Cochrane Database Syst Rev. 2020; 5:CD011737.
PMID: 32428300 PMC: 7388853. DOI: 10.1002/14651858.CD011737.pub2.
Smith S, Lake A, Summerbell C, Araujo-Soares V, Hillier-Brown F Syst Rev. 2016; 5:20.
PMID: 26842069 PMC: 4740991. DOI: 10.1186/s13643-016-0200-1.